
Reset all filters
01 3Bausch & Lomb Incorporated
02 1Indiana Ophthalmics
Reset all filters
01 1OPD
02 1Ophthalmic Suspension
03 1SUSPENSION
04 1SUSPENSION/DROPS;OPHTHALMIC
Reset all filters
01 1Originator
02 1RX
03 2Blank
Reset all filters
01 2BESIVANCE
02 1Besivance
03 1Blank
Reset all filters
01 1Canada
02 1India
03 1South Africa
04 1USA
Regulatory Info : RX
Registration Country : USA
Brand Name : BESIVANCE
Dosage Form : SUSPENSION/DROPS;OPHTHALMIC
Dosage Strength : EQ 0.6% BASE
Packaging :
Approval Date : 2009-05-28
Application Number : 22308
Regulatory Info : RX
Registration Country : USA
Regulatory Info :
Registration Country : Canada
BESIFLOXACIN (BESIFLOXACIN HYDROCHLORIDE)
Brand Name : BESIVANCE
Dosage Form : SUSPENSION
Dosage Strength : 0.6%/W/V
Packaging : 2ML/5ML
Approval Date :
Application Number : 2336847
Regulatory Info :
Registration Country : Canada
Regulatory Info : Originator
Registration Country : South Africa
Brand Name : Besivance
Dosage Form : OPD
Dosage Strength : 6mg/ml
Packaging : 5X1mg/ml
Approval Date :
Application Number :
Regulatory Info : Originator
Registration Country : South Africa
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Ophthalmic Suspension
Dosage Strength : 0.6%/W/V
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India